- Visibility 292 Views
- Downloads 304 Downloads
- Permissions
- DOI 10.18231/j.ijmmtd.v.11.i.3.5
-
CrossMark
Study of risk factors and biofilm formation among non albicans candida species in neonatal Candidemia
- Author Details:
-
Rahul Gopichand Wadile *
-
Ravidas Arjun Vasave
-
Vijay Rajput Kokani
Rahul Gopichand Wadile *
Ravidas Arjun Vasave
Vijay Rajput Kokani
Background: The changes in virulence factors associated with NAC species in neonatal candidemia were the subject of this study. The study was conducted in a rural tertiary referral teaching hospital of northern Maharashtra, India.
Materials and Methods: The research took place over the course of a year from January to December 2022, with all data collected and analyzed in real time. Blood samples were taken aseptically from newborns admitted to the neonatal intensive care unit (NICU) who showed symptoms that could indicate sepsis. Samples were inoculated in Brain Heart infusion broth, incubated at 370C for overnight incubation & subcultured on blood agar and SDA slant. Fungi was then further characterized through microscopic examination, biochemical assays, and observation of its growth patterns on selective media. These strains exhibited virulence factors were identified through the study of biofilm formation and other characteristics.
Result: Out of 383 neonates, Blood culture was positive in 269 (70.23%) cases. 87 were positive for Candida species (32.34%). NAC species were 68 (78.16%) and C. albicans 19 (21.84%). C. tropicalis was the most frequent non albicans species then by C. glabrata and C. krusei. Premature birth and low birth weight were the primary risk factors. Hemolysin production was frequent virulence factor then by Biofilm & Proteases production among all candida isolates.
Conclusion: When NAC species are detected in neonatal candidemia, a mycological shift in direction indicates a changed tendency and the escalating issue of anti-mycological resistance. Because of their increasing prevalence, NAC species identification is important for prompt management, appropriate anti-mycological medication selection, and preventing the development of antifungal resistances.
References
- Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 2003;3(11):685–702.
- Chander J. Texbook of Medical Mycology, 4th edition: Jaypee Brothers Medical Publisher; 2018.
- Winn W, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P. et al, editors. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology, 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2006.
- Caggiano G, Lovero G, De Giglio O, Barbuti G, Montagna O, Laforgia N, Montagna MT. Candidemia in the Neonatal Intensive Care Unit: A Retrospective, Observational Survey and Analysis of Literature Data. BioMed Res Int. 2017;2017:7901763.
- Benjamin DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117(1):84–92.
- Shetty SS, Harrison LH, Hajjeh RA, Taylor T, Mirza SA, Schmidt AB, et al. Determining risk factors for candidemia among newborn infants from population-based surveillance: Baltimore, Maryland, 1998-2000. Pediatr Infect Dis J. 2005;24(7):601–4.
- Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non – albicans candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2012;136(6):997–1003.
- Juyal D, Adekhandi S, Negi V, Sharma N. An Outbreak Of Neonatal Candidemia Due To Non-Albicans Candida Species In A Resource Constrained Setting Of Uttarakhand State. Ind J Clin Neonatal. 2013;2(4):183–6.
- Chapman RL. Candida infections in the neonate. Curr Opin Pediatr. 2003;15(1):97–102.
- Agarwal J, Bansal S, Malik GK, Jain A. Trends in neonatal septicemia: emergence of non-albicans Candida. Indian Pediatr. 2004;41(7):712-5
- Adib SM, Bared EE, Fanous R, Kyriacos S. Practices of Lebanese gynecologists regarding treatment of recurrent vulvovaginal candidiasis. N Am J Med Sci. 2011;3(9):406–10.
- McGinnis MR. Laboratory Handbook of Medical Mycology. 1st Edition. New York: Academic Press. 1980:337–73.
- Price MF, Cawson RA. Phospholipase activity in Candida albicans. Sabouraudia. 1977;15(2):179–85.
- Nazir A. Non-albicans Candida in Neonatal Septicemia: An emerging clinical entity. Int J Biomed Res. 2016;7(2):47–50.
- Sardana V, Pandey A, Madan M, Goel SP, Asthana AK. Neonatal candidemia: A changing trend. Indian J Pathol Microbiol. 2012;55(1):132-3.
- Rani R, Mohapatra NP, Mehta G, Randhawa VS. Changing trends of Candida species in neonatal septicemia in a tertiary North Indian hospital. Indian J Med Microbiol. 2002;20(1):42–4.
- Baradkar VP, Mathur M, Kumar S, Rathi M. Candida glabrata emerging pathogen in neonatal sepsis. Ann Trop Med Public Health. 2008;1:5–8.
- Kothari A, Sagar V. Epidemiology of Candida bloodstream infections in a tertiary care institute in India. Indian J Med Microbiol. 2009;27(2):171–2.
- Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: Its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59(pt.8):873–80.
- Giri S, Kindo AJ. A review of Candida species causing blood stream infection. Indian J Med Microbiol. 2012;30(3):270–8.
- Goel N, Rajan PK, Aggarwal R, Chaudhary U, Sanjeev N. Emergence of NAC species in neonatal septicemia and antifungal susceptibility: Experience from a tertiary care center. J Lab physicians. 2009;1(2):53–5.
- Shrivastava G, Bajpai T, Bhatambare GS, Chitnis V, Deshmukh AB. Neonatal candidemia: Clinical importance of species identification. Sifa Med J. 2015;2(2):37–40.
- Srinivas Rao MS, Surendranath M, Sandeepthi M. Prevalence of neonatal candidemia in a tertiary care institution in Hyderabad, South India. Int J Res Med Sci. 2014;2(3):1016–9.
- Hartung de Capriles C, Mata-Essayag S, Azpiróz A, Ponente A, Magaldi S, Pérez C, et al. Neonatal candidiasis in Venezuela: Clinical and epidemiological aspects. Rev Latinoam Microbiol. 2005;47(1-2):11–20.
- Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21(4):606–25.
- Bonassoli LA, Bertoli M, Svidzinski TI. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect. 2005;59(2):159–62.
- Almirante B, Rodríguez D, Cuenca-Estrella M, Almela M, Sanchez F, Ayats J, et al. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2006;44(5):1681–5.
- Narang A, Agarwal PB. Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Pediatr. 1998;44(2):104–8.
- Romeo Reyes MC, Fernandez Gutierrez F, Poyato Dominguez JL, Párraga Quiles MJ, Huertas Muñoz MD, Cabañas JG, et al. Neonatal systemic candidiasis in the nineties. An Esp Pediatr. 1996;44(3):257–61.